Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Buter

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|August 3, 2013
Cetuximab in locally advanced squamous cell carcinoma of the head and neck: generalizability of EMR 062202-006 trial resultsNaomi van der Linden, C W M van Gils, C P Pescott, et al.
The British Journal of Oral & Maxillofacial Surgery|October 18, 2011
Subset of patients with verrucous carcinoma of the oral cavity who benefit from treatment with methotrexateK H Karagozoglu, J Buter, C R Leemans, et al.
Seminars in Oncology|December 1, 1993
A progress report on the outpatient treatment of patients with advanced renal cell carcinoma using subcutaneous recombinant interleukin-2J Buter, D T Sleijfer, W T van der Graaf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1994
High dose oral amiodarone added to doxorubicin and vindesine for overcoming multidrug resistance in solid tumorsW T van der Graaf, J Buter, E G de Vries, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|June 20, 2014
Real-world cost-effectiveness of cetuximab in locally advanced squamous cell carcinoma of the head and neckN van der Linden, C W M van Gils, C P Pescott, et al.
British Journal of Cancer|September 1, 1995
Immunomodulatory effects of intravenous BIS-1 F(ab')2 administration in renal cell cancer patientsR A Janssen, B J Kroesen, J Buter, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|August 7, 2015
Salvage surgery in post-chemoradiation laryngeal and hypopharyngeal carcinoma: outcome and reviewL Putten, R Bree, P A Doornaert, et al.
Oral Oncology|March 2, 2011
Salvage laryngectomy: oncological and functional outcomeL van der Putten, R de Bree, D J Kuik, et al.
Anticancer Research|May 1, 1994
Dose escalation of dacarbazine combined with interferon alpha-2a, G-CSF and ondansetron in patients with metastatic melanomaJ Buter, D T Sleijfer, P H Willemse, et al.
British Journal of Cancer|October 1, 1994
Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2B J Kroesen, J Buter, D T Sleijfer, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|August 3, 2013
Cetuximab in locally advanced squamous cell carcinoma of the head and neck: generalizability of EMR 062202-006 trial resultsNaomi van der Linden, C W M van Gils, C P Pescott, et al.
The British Journal of Oral & Maxillofacial Surgery|October 18, 2011
Subset of patients with verrucous carcinoma of the oral cavity who benefit from treatment with methotrexateK H Karagozoglu, J Buter, C R Leemans, et al.
Seminars in Oncology|December 1, 1993
A progress report on the outpatient treatment of patients with advanced renal cell carcinoma using subcutaneous recombinant interleukin-2J Buter, D T Sleijfer, W T van der Graaf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1994
High dose oral amiodarone added to doxorubicin and vindesine for overcoming multidrug resistance in solid tumorsW T van der Graaf, J Buter, E G de Vries, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|June 20, 2014
Real-world cost-effectiveness of cetuximab in locally advanced squamous cell carcinoma of the head and neckN van der Linden, C W M van Gils, C P Pescott, et al.
British Journal of Cancer|September 1, 1995
Immunomodulatory effects of intravenous BIS-1 F(ab')2 administration in renal cell cancer patientsR A Janssen, B J Kroesen, J Buter, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|August 7, 2015
Salvage surgery in post-chemoradiation laryngeal and hypopharyngeal carcinoma: outcome and reviewL Putten, R Bree, P A Doornaert, et al.
Oral Oncology|March 2, 2011
Salvage laryngectomy: oncological and functional outcomeL van der Putten, R de Bree, D J Kuik, et al.
Anticancer Research|May 1, 1994
Dose escalation of dacarbazine combined with interferon alpha-2a, G-CSF and ondansetron in patients with metastatic melanomaJ Buter, D T Sleijfer, P H Willemse, et al.
British Journal of Cancer|October 1, 1994
Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2B J Kroesen, J Buter, D T Sleijfer, et al.
Pageof 5